•
Sep 30, 2017

Emergent BioSolutions Q3 2017 Earnings Report

Total Revenue
$149M
Previous year: $143M
+4.6%
EPS
$0.74
Previous year: $0.58
+27.6%
Gross Profit
$105M
Previous year: $103M
+1.5%
Cash and Equivalents
$341M
Previous year: $299M
+14.1%
Free Cash Flow
$20.7M
Previous year: $10.1M
+105.8%
Total Assets
$1.02B
Previous year: $932M
+9.9%

Emergent BioSolutions

Emergent BioSolutions